
Loading, please wait...

Loading, please wait...

Surgical management of medullary gliomas is exceptionally challenging due to high neurological risks. Specifically, medullary glioma surgery frequently leads to lower cranial nerve (LCN) dysfunction, which significantly impacts a patient's overall quality of life. Consequently, clinicians often struggle to balance maximal tumor removal with the preservation of vital neurological functions. Researchers published a predictive model in the Journal of Neurosurgery to address this clinical gap. This model integrates clinical and imaging data to forecast short-term postoperative LCN impairment effectively.
Moreover, the research identified four independent risk factors that drive these surgical complications. These factors include the extent of resection (EOR), infiltrative growth patterns, preoperative LCN impairment, and cervical cord involvement. Furthermore, the model demonstrated excellent predictive performance with an area under the curve (AUC) of 0.89 in prospective validation. Notably, the study identifies a specific risk threshold of 0.471 using the Youden index. High-risk patients exceeding this threshold experienced higher rates of pneumonia and tracheostomy.
Therefore, the researchers proposed a dynamic resection paradigm to optimize clinical outcomes. Low-risk patients benefited from gross-total resection, achieving an average EOR of 88.4%. Conversely, high-risk patients achieved the best functional results through more limited resections of approximately 40.8%. This individualized approach ensures that surgical intensity matches the patient's specific physiological tolerance. Additionally, the use of SHAP analysis and nomograms provides a transparent tool for preoperative counseling. Ultimately, this assessment system empowers neurosurgeons to make data-driven intraoperative decisions during medullary glioma surgery.
The four primary predictors identified are the extent of resection (EOR), infiltrative tumor growth, existing preoperative LCN impairment, and involvement of the cervical cord. These factors significantly increase the likelihood of needing prolonged ventilation or tracheotomy post-surgery.
The model categorizes patients into low-risk and high-risk groups. Low-risk patients can safely undergo more aggressive tumor removal (gross-total resection), while high-risk patients achieve better functional outcomes with a more conservative, limited resection strategy.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not intended to replace professional medical advice from a qualified healthcare provider. Always seek the advice of your physician or other qualified health professional with any questions regarding a medical condition. The model described is a tool for clinical research and should be integrated with expert surgical judgment. Refer to the latest local and national guidelines for clinical practice.
References
Zhang M et al. Assessment system for short-term lower cranial nerve dysfunction following medulla oblongata glioma surgery: risk stratification and optimal surgical strategy. J Neurosurg. 2026 May 29. doi: 10.3171/2025.12.JNS251593. PMID: 42214095.
Chang EF et al. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg. 2008 Nov;109(5):817-24. doi: 10.3171/JNS/2008/109/11/0817.
Schucht P et al. Extending resection and preserving function: modern concepts of glioma surgery. Swiss Med Wkly. 2015;145:w14082. doi: 10.4414/smw.2015.14082.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new predictive model helps neurosurgeons manage LCN dysfunction risks in medullary glioma surgery, optimizing tumor removal and functional preservation....
4 months ago

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A novel calcium polyphosphate coacervate enables injectable bone implants with in situ hierarchical porosity via phase separation and gas foaming, significantly enhancing cell proliferation, energy metabolism, and osteogenic differentiation for minimally invasive bone defect repair.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today